IT8609514A0 - Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso. - Google Patents

Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.

Info

Publication number
IT8609514A0
IT8609514A0 IT8609514A IT951486A IT8609514A0 IT 8609514 A0 IT8609514 A0 IT 8609514A0 IT 8609514 A IT8609514 A IT 8609514A IT 951486 A IT951486 A IT 951486A IT 8609514 A0 IT8609514 A0 IT 8609514A0
Authority
IT
Italy
Prior art keywords
octilonium
gastro
dci
bromide
pharmaceutical formulation
Prior art date
Application number
IT8609514A
Other languages
English (en)
Other versions
IT1216283B (it
Inventor
Casini Alessandro
Parti Sandro
Bucci Paolo
Original Assignee
Menarini Sas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Sas filed Critical Menarini Sas
Priority to IT8609514A priority Critical patent/IT1216283B/it
Publication of IT8609514A0 publication Critical patent/IT8609514A0/it
Priority to CA000550314A priority patent/CA1311419C/en
Priority to ES87830386T priority patent/ES2058138T3/es
Priority to AT87830386T priority patent/ATE94388T1/de
Priority to EP87830386A priority patent/EP0270503B1/en
Priority to DE87830386T priority patent/DE3787448T2/de
Priority to JP62277534A priority patent/JP2514670B2/ja
Priority to US07/117,751 priority patent/US4978772A/en
Application granted granted Critical
Publication of IT1216283B publication Critical patent/IT1216283B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
    • A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
    • A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Endoscopes (AREA)
  • Steroid Compounds (AREA)
IT8609514A 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso. IT1216283B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT8609514A IT1216283B (it) 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.
CA000550314A CA1311419C (en) 1986-11-04 1987-10-27 Utilization of otilonium bromide for topical application in the gastrointestinal tract and pharmaceutical formulations appropriate for such use
ES87830386T ES2058138T3 (es) 1986-11-04 1987-11-03 Utilizacion de bromuro de otilonio (dci) para aplicacion topica en el tracto gastrointestinal y formulacion farmaceutica correspondiente apropiada de un uso de esta indole.
AT87830386T ATE94388T1 (de) 1986-11-04 1987-11-03 Verwendung von otiloniumbromid fuer die topische anwendung im gastrointestinaltrakt und entsprechende geeignete pharmazeutische formulierung.
EP87830386A EP0270503B1 (en) 1986-11-04 1987-11-03 Utilization of bromure d'otilonium (dci) for topic application in the gastrointestinal tract and relative pharmaceutical formulation appropriate for such use
DE87830386T DE3787448T2 (de) 1986-11-04 1987-11-03 Verwendung von Otiloniumbromid für die topische Anwendung im Gastrointestinaltrakt und entsprechende geeignete pharmazeutische Formulierung.
JP62277534A JP2514670B2 (ja) 1986-11-04 1987-11-04 オチロニウム ブロマイド含有製薬組成物
US07/117,751 US4978772A (en) 1986-11-04 1987-11-04 Utilization of otilonium bromide (DCI) for topical application in the gastroinstestinal tract and related pharmaceutical formulation appropriate for such use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8609514A IT1216283B (it) 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.

Publications (2)

Publication Number Publication Date
IT8609514A0 true IT8609514A0 (it) 1986-11-04
IT1216283B IT1216283B (it) 1990-02-22

Family

ID=11131395

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8609514A IT1216283B (it) 1986-11-04 1986-11-04 Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.

Country Status (8)

Country Link
US (1) US4978772A (it)
EP (1) EP0270503B1 (it)
JP (1) JP2514670B2 (it)
AT (1) ATE94388T1 (it)
CA (1) CA1311419C (it)
DE (1) DE3787448T2 (it)
ES (1) ES2058138T3 (it)
IT (1) IT1216283B (it)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100503889B1 (ko) * 2002-07-20 2005-07-26 한국과학기술연구원 옥틸로늄 브로마이드를 함유하는 항암제 흡수 증진제
TR201111221T2 (tr) * 2009-02-12 2012-02-21 Abd� �Brah�M �La� Sanay� Ve T�Caret Anon�M ��Rket�@ Simetikon ve otilonyumun farmasötik kombinasyonları.
EP2481395A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Sachet, effervescent tablet and dry syrup of otilonium
EP2481403A1 (en) 2011-02-01 2012-08-01 Deva Holding Anonim Sirketi Pharmaceutical combination of otilonium and trimebutine
US20180311201A1 (en) 2015-06-12 2018-11-01 Santa Farma ?Laç Sanay? A. ?. Oral pharmaceutical composition comprising otilonium bromide and simethicone with certain bulk density and improved dissolution characteristics

Also Published As

Publication number Publication date
ATE94388T1 (de) 1993-10-15
JP2514670B2 (ja) 1996-07-10
IT1216283B (it) 1990-02-22
JPS63130530A (ja) 1988-06-02
DE3787448D1 (de) 1993-10-21
EP0270503A3 (en) 1990-04-18
EP0270503A2 (en) 1988-06-08
EP0270503B1 (en) 1993-09-15
ES2058138T3 (es) 1994-11-01
US4978772A (en) 1990-12-18
CA1311419C (en) 1992-12-15
DE3787448T2 (de) 1994-01-13

Similar Documents

Publication Publication Date Title
DE3689384D1 (de) Arzneimittel zur topischen Anwendung.
DE3786481D1 (de) Topische antimikrobielle arzneimittel.
FI943571A0 (fi) 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset
EE03111B1 (et) Glükokortikosteroidi epimeerid, nende valmistamise protsessid ja neid sisaldavad ravimpreparaadid
IT1212778B (it) Composizioni farmaceutiche adattivita' antiinfiammatoria e/o analgesica, non ulcerogene.
NO980317L (no) Anvendelse av Calendula-glykosider for behandling av psoriasis
IT8609514A0 (it) Utilizzazione di ottilonio bromuro (dci) per applicazione topica nel tratto gastro-intestinale e relativa formulazione farmaceutica appropriata per tale uso.
ITRM930286A0 (it) Composizione farmaceutica per somministrazione rettale nel trattamentodi cefaleo e relativo metodo di preparazione ed impiego.
IT8619284A0 (it) Composizione per la preparazione estemporanea di formulazioni per applicazioni topiche per uso farmaceutico e cosmetico.
IT1151723B (it) Uso di antibiotici macrolidi nel controllo di infezioni da pasteurella
IT8521945A0 (it) 2-piridilcarbossammide particolarmente per uso farmaceutico.
IT8423517A1 (it) Composizione farmaceutica per combattere infezioni virali, e procedimento di uso per le infezioni virali
DK578589A (da) Farmaceutisk praeparat indeholdende labdanterpenoidderivater og pyrimido(6,1-a)isoquinolin-4-onderivater, dets fremstilling og anvendelse
IT8319600A0 (it) Composizioni farmaceutiche e loro uso nel trattamento del glaucoma.
NO883609L (no) Farmasoeytiske preparater for topisk anvendelse.
DK330687D0 (da) Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler
ES2128353T3 (es) Composicion topica que contiene penciclovir.
GR3004113T3 (it)
IT8621695A0 (it) Preparazione farmaceutica per uso veterinario.
IT8220818A0 (it) Uso di 5-0-micaminosil tilonolide nel controllo di infezioni da pasteurella.
IT8420939A0 (it) Composizioni farmaceutiche comprendenti solfo-afenosil-l-metionina (same)particolarmente adatte per uso orale e per supposte.
MX9203485A (es) Derivados de tieno sulfonamida, composiciones farmaceuticas y uso.
IT8321384A0 (it) Anticatarrata. preparazioni farmaceutiche per uso
ITRM920351A0 (it) Formulazione farmaceutica per uso topico, indicata nel trattamento di infezioni virali della pelle e delle mucose.
ITGE940025A0 (it) Preparazione farmaceutica ad uso topico per la cura della psoriasi e di altre dermatosi.

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19981127